Abstract
Autologous PBPC transplantation is a potentially curative treatment for patients with chronic lymphocytic leukemia (CLL). As the autografts are frequently contaminated with large numbers of tumor cells, we have studied double purging of PBPC using immunomagnetic CD34+ cell selection (Isolex 300i) followed by negative depletion with anti-CD19/20/23/37-labeled immunomagnetic beads. In four small-scale experiments using PBPC from patients with CLL or leukemic low-grade lymphoma, double purging resulted in CD34+ enrichment from 0.9–4.4% to 95.8–99.4%. Lymphoma cells were always undetectable by FACS and PCR (CDR3 or t(14;18)) after negative depletion. Next, seven heavily contaminated full grafts from five patients with CLL or lymphoplasmocytoid immunocytoma were subjected to the double purging procedure, resulting in a CD34+ enrichment from 1.6% (0.7–5.6) to 98.5% (96–99.8). The CD34+ yield after double purging was 1.3–6.3 × 106/kg, according to a median recovery of 32%. The overall reduction of lymphoma cells was 5.6 (>4.6–6) log. Although CLL cells were completely absent after purging in five cases as assessed by FACS, all grafts remained PCR positive. The first two patients have been reinfused with double selected products after myeloablative radiochemotherapy and showed prompt and uneventful hematopoietic engraftment. We conclude that without significant loss of CD34+ cells, negative depletion adds 2 log of CLL cell depletion to CD34+ selection, resulting in an overall purging efficacy of more than 5 log. This combination of positive and negative selection can be successfully applied even to heavily contaminated PBPC grafts.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paulus, U., Schmitz, N., Viehmann, K. et al. Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL. Bone Marrow Transplant 20, 415–420 (1997). https://doi.org/10.1038/sj.bmt.1700914
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700914
Keywords
This article is cited by
-
Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation
Bone Marrow Transplantation (2007)
-
Allogeneic and autologous transplantation for chronic lymphocytic leukemia
Leukemia (2001)
-
CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma
Bone Marrow Transplantation (2000)
-
Hepatitis B viremia in a patient with documented previous HBV immunity after autologous transplantation of highly purified PBSC
Bone Marrow Transplantation (2000)
-
Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells
Bone Marrow Transplantation (2000)